Otsuka Holdings Grants Restricted Stock to Directors Tied to Medium-Term Performance Targets

Otsuka Holdings Co ( (JP:4578) ) just unveiled an announcement.

Otsuka Holdings will dispose of 83,920 treasury shares as restricted stock compensation for eight directors of the parent company and 35 directors of major subsidiaries, at ¥11,090 per share for a total value of about ¥930.7 million. The stock awards, subject to transfer restrictions until June 1, 2031, are funded through directors’ monetary compensation receivables contributed in kind.

The plan is designed to align management incentives with Otsuka’s medium- to long-term performance and corporate value, tying vesting to financial indicators such as EPS, TSR, ROIC, and cash flow, as well as ESG-related external evaluations under the Fourth Medium-Term Management Plan. Unvested shares or those linked to unmet performance or service conditions will be acquired by the company without compensation, reinforcing performance-linked governance and shareholder value alignment.

The most recent analyst rating on (JP:4578) stock is a Buy with a Yen13200.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.

More about Otsuka Holdings Co

Otsuka Holdings Co., Ltd. is a Japan-based healthcare group listed on the Prime Market of the Tokyo Stock Exchange, operating through key subsidiaries such as Otsuka Pharmaceutical, Otsuka Pharmaceutical Factory, Taiho Pharmaceutical, Otsuka Chemical, Otsuka Foods, Otsuka Warehouse, and Otsuka Medical Devices. The group focuses on pharmaceuticals, nutraceuticals, medical devices, chemicals, and related businesses, targeting domestic and global markets in both prescription drugs and consumer health products.

Average Trading Volume: 1,275,873

Technical Sentiment Signal: Buy

Current Market Cap: Yen5850.6B

Learn more about 4578 stock on TipRanks’ Stock Analysis page.